Myriad Genetics, Inc. (MYGN) Free Cash Flow
Myriad Genetics, Inc. (MYGN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-06-30 | $161.30M |
| 2017-06-30 | $100.10M |
| 2018-06-30 | $107.50M |
| 2019-06-30 | $75.10M |
| 2020-06-30 | $50.50M |
| 2021-12-31 | $600.00K |
| 2022-12-31 | -$151.60M |
| 2023-12-31 | -$184.20M |
| 2024-12-31 | -$38.40M |
| 2025-12-31 | -$25.60M |
How MYGN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| TGTX | TG Therapeutics Inc. | -$24.99M |
| ATOS | Atossa Therapeutics Inc. | -$29.79M |
| CRVS | Corvus Pharmaceuticals Inc. | -$32.97M |
| TRVI | Trevi Therapeutics Inc. | -$42.10M |
| RLMD | Relmada Therapeutics Inc. | -$45.79M |
These are five companies in the same sector as MYGN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Myriad Genetics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("MYGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MYGN | $3.16 | -0.63% | 1.43M |
| 3 | ||||
| 4 | ||||
| 5 |